Literature DB >> 16846802

Hit discovery and hit-to-lead approaches.

György M Keseru1, Gergely M Makara.   

Abstract

Hit discovery technologies range from traditional high-throughput screening to affinity selection of large libraries, fragment-based techniques and computer-aided de novo design, many of which have been extensively reviewed. Development of quality leads using hit confirmation and hit-to-lead approaches present their own challenges, depending on the hit discovery method used to identify the initial hits. In this paper, we summarize common industry practices adopted to tackle hit-to-lead challenges and review how the advantages and drawbacks of different hit discovery techniques could affect the various issues hit-to-lead groups face.

Mesh:

Year:  2006        PMID: 16846802     DOI: 10.1016/j.drudis.2006.06.016

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  34 in total

1.  The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA.

Authors:  Andreas Schüller; Marcel Suhartono; Uli Fechner; Yusuf Tanrikulu; Sven Breitung; Ute Scheffer; Michael W Göbel; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2007-12-07       Impact factor: 3.686

Review 2.  The influence of lead discovery strategies on the properties of drug candidates.

Authors:  György M Keserü; Gergely M Makara
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

3.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.

Authors:  Kristin E D Coan; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2008-06-28       Impact factor: 15.419

4.  Targeting the target of rapamycin (TOR): looking to mother nature.

Authors:  Eric K Rowinsky
Journal:  Target Oncol       Date:  2011-04-27       Impact factor: 4.493

5.  Inhibition of protein-protein interactions with low molecular weight compounds.

Authors:  Marilyn M Matthews; David J Weber; Paul S Shapiro; Andrew Coop; Alexander D Mackerell
Journal:  Curr Trends Med Chem       Date:  2008-01-01

Review 6.  Evolutions in fragment-based drug design: the deconstruction-reconstruction approach.

Authors:  Haijun Chen; Xiaobin Zhou; Ailan Wang; Yunquan Zheng; Yu Gao; Jia Zhou
Journal:  Drug Discov Today       Date:  2014-09-27       Impact factor: 7.851

7.  Identification of novel inhibitors of human Chk1 using pharmacophore-based virtual screening and their evaluation as potential anti-cancer agents.

Authors:  Vikash Kumar; Saman Khan; Priyanka Gupta; Namrata Rastogi; Durga Prasad Mishra; Shakil Ahmed; Mohammad Imran Siddiqi
Journal:  J Comput Aided Mol Des       Date:  2014-10-14       Impact factor: 3.686

8.  Colloid formation by drugs in simulated intestinal fluid.

Authors:  Allison K Doak; Holger Wille; Stanley B Prusiner; Brian K Shoichet
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

9.  Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen.

Authors:  Michelle Lewis; Charles David Weaver; Mark S McClain
Journal:  Toxins (Basel)       Date:  2010-07-01       Impact factor: 5.075

10.  Optimizing Dvl PDZ domain inhibitor by exploring chemical space.

Authors:  Jufang Shan; Jie J Zheng
Journal:  J Comput Aided Mol Des       Date:  2008-09-09       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.